Guidance for the X-TOLE2 Phase 3 epilepsy study shifted from the second half of 2025 to "early next year," reflecting a slight timeline delay. Management's strategic focus remains on advancing ...

CytoTronics, Inc., a pioneer of semiconductor-based platforms for discovery in cell biology, launched their novel Cardiac application today-the next key offering in its Pixel application portfolio.

Q1 2025 Earnings Conference Call May 13, 2025 8:30 AM ETCompany ParticipantsLee Roth - President, Burns McClellan, ...

Here's a ChatGPT guide to help understand Open AI's viral text-generating system. We outline the most recent updates and ...

RIZE enrollment on track including U.S. sites and expected to be completed in May 2025; topline data anticipated in December 2025 U.S. Food and Drug Administration (FDA) grants Breakthrough Therapy ...

The bear market induced by the Federal Reserve’s monetary tightening officially ended in 2023, but it seems no one remembered ...

Submitted NDA for Anaphylm (epinephrine), the first and only oral sublingual film for patients with severe allergic reactions Advancing commercial readiness efforts with a planned Q1 2026 launch of An ...

India already has a homegrown CAR T-cell therapy, and other regions are exploring their own strategies, including developing them at the point of care.

Orphan drug developers face significant difficulties when navigating market access frameworks in Europe. Could greater use of ...

Anebulo Pharmaceuticals, Inc. (Nasdaq: ANEB), a clinical-stage pharmaceutical company developing novel solutions for people suffering from acute cannabis-induced toxic effects (the "Company" or ...

OncoCyte Corp (OCX) reports significant progress in clinical trials and revenue growth, despite facing challenges in oncology ...

Long-threatened tariffs from U.S. President Donald Trump have plunged the country into trade wars abroad — all while on-again ...